Golden State Equity Partners’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-350
Closed -$215K – 442
2025
Q1
$215K Sell
350
-174
-33% -$98.9K 0.04% 400
2024
Q4
$278K Sell
524
-225
-30% -$127K 0.05% 350
2024
Q3
$450K Sell
749
-287
-28% -$163K 0.07% 270
2024
Q2
$562K Buy
+1,036
New +$593K 0.12% 190
2023
Q4
$508K Buy
869
+196
+29% +$110K 0.12% 189
2023
Q3
$350K Buy
673
+153
+29% +$79.5K 0.1% 220
2023
Q2
$282K Buy
+520
New +$284K 0.08% 293

Other funds holding CHE

Golden State Equity Partners's CHE Position: Q2 2025 in Review

Golden State Equity Partners sold out of Chemed (CHE) in Q2 2025, closing a stake of 350 shares — an estimated $215K sold.

Golden State Equity Partners first reported a position in CHE in Q2 2023 and held it in 7 quarters. The position peaked at $562K in Q2 2024. 538 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

  • Golden State Equity Partners reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
  • Golden State Equity Partners sold 350 Chemed shares in Q2 2025, an estimated $215K.
  • Golden State Equity Partners first reported a position in Chemed in Q2 2023 and held it in 7 quarters.
  • Golden State Equity Partners's Chemed position peaked at $562K in Q2 2024.
  • 538 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Golden State Equity Partners's 13F filing for Q2 2025, filed 14 Jul 2025.